Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A clinical trial with an interim analysis.

P Y Chi, D R Bristol, J V Castellana

    Statistics in Medicine
    |July 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Study of cytochrome bo function in Vitreoscilla using a cyo(-) knockout mutant.

    Journal of biochemistry·2000
    Same author

    Clinical equivalence.

    Journal of biopharmaceutical statistics·1999
    Same author

    Worm recovery and precipitin antibody response in guinea pigs and rats infected with Clonorchis sinensis.

    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi·1999
    Same author

    p-value adjustments for subgroup analyses.

    Journal of biopharmaceutical statistics·1997
    Same author

    Alcohol-containing mouthwashes and oropharyngeal cancer: a spurious association due to underascertainment of confounders?

    American journal of epidemiology·1996
    Same author

    Determining equivalence and the impact of sample size in anti-infective studies: a point to consider.

    Journal of biopharmaceutical statistics·1996

    This study examines clinical trial design with interim analysis. Performing interim analysis does not significantly impact type I error rates or power for certain critical regions when the null hypothesis is not rejected.

    Area of Science:

    • Biostatistics
    • Clinical Trial Design
    • Statistical Inference

    Background:

    • Interim analyses are often incorporated into clinical trials to allow for early stopping or modification.
    • Sequential analysis methods can affect the overall Type I error rate and statistical power.
    • Careful design is needed to ensure the validity of final results after interim looks.

    Purpose of the Study:

    • To evaluate the impact of interim analysis on statistical properties of a fixed-sample parallel-group clinical trial.
    • To determine if specific critical regions mitigate inflation of Type I error and power reduction.
    • To assess the validity of hypothesis testing in clinical trials with a planned interim analysis.

    Main Methods:

    • The study considers a fixed-sample parallel-group clinical trial design.

    Related Experiment Videos

  • It involves a hypothesis test of H0: mu x = mu y versus H1: mu x < mu y.
  • The analysis focuses on the consequences of not rejecting H0 at an interim analysis for specific critical regions.

    • Main Results:

    • For certain critical regions, the probability of a Type I error is not appreciably affected by the interim analysis.
    • The power of the final analysis is also not significantly impacted under these conditions.
    • This suggests that specific interim analysis designs can maintain trial integrity.

    Conclusions:

    • Interim analyses in clinical trials can be performed without compromising statistical validity under specific conditions.
    • The choice of critical regions is crucial for maintaining Type I error control and power.
    • This research provides guidance for designing robust clinical trials with interim analyses.